Regeneron to acquire 23andMe's assets, including its genetic data, in a bankruptcy deal, aiming to enhance drug development while prioritizing privacy and ethics.
Biden's cancer diagnosis sparks political controversy over transparency and partisan tensions.
Regeneron to acquire 23andMe's assets, including its genetic data, in a bankruptcy deal, aiming to enhance drug development while prioritizing privacy and ethics.
Biden's cancer diagnosis sparks political controversy over transparency and partisan tensions.